Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lung (Fibrosis).php on line 2
Lung (Fibrosis)
LE WE PMID CA
Lung (Fibrosis)1647Lunge (Fibrose)

Anemia (aplastic)

Bleomycin

Endothelin

Endothelio mesenchymal transition

Fibroblastic foci

Fibrocyte

Gastroesophageal reflux disease

Herpesvirus (BASKET)

HGF

Hoyeraal Hreidarsson syndrome

Interleukin10

Lung (Development)

Lung (Fibrosis)

Pirfenidone

Pulmonary function testing

Pulmonary hypertension

RAAS (ACE inhibitor)

Regeneration of tissues and other biologic structures

SNM1B Apollo

Statin

Stem cell (BASKET)

Telomerase

1974  
1
A perspective view on widespread pulmonary fibrosis.
[4599148] Br Med J 2(5915): 371-6 (1974)
2006  
2
Idiopathic pulmonary fibrosis: an update.
[16956923] QJM 99(10): 643-54 (2006)
2005  
3
Idiopathic pulmonary fibrosis.
[15727572] Allergy 60(4): 421-35 (2005)
2008  
4
2007  
5
Acute exacerbations of idiopathic pulmonary fibrosis.
[17585107] Am J Respir Crit Care Med 176(7): 636-43 (2007)
2000  
6
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).
[10673212] Am J Respir Crit Care Med 161(2 Pt 1): 646-64 (2000)
1998  
7
Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.
[9563754] Am J Respir Crit Care Med 157(4 Pt 1): 1301-15 (1998)
2007  
8
Acute exacerbation of idiopathic pulmonary fibrosis.
[17998366] Chest 132(5): 1652-8 (2007)
2007  
9
Recent advances in idiopathic pulmonary fibrosis.
[17699135] Chest 132(2): 637-50 (2007)
2007  
10
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
[17978154] Eur Respir J 30(5): 835-9 (2007)
2005  
11
Current and future therapeutic approaches in idiopathic pulmonary fibrosis.
[16204603] Eur Respir J 26(4): 693-702 (2005)
2005  
12
Genetics of fibrosing lung diseases.
[15863652] Eur Respir J 25(5): 915-27 (2005)
2003  
13
Acute exacerbation of idiopathic pulmonary fibrosis: report of a series.
[14621091] Eur Respir J 22(5): 821-6 (2003)
1994  
14
From granuloma to fibrosis in interstitial lung diseases: molecular and cellular interactions.
[8005262] Eur Respir J 7(4): 779-85 (1994)
2008  
15
Idiopathic pulmonary fibrosis.
[18366757] Orphanet J Rare Dis 3(-): 8 (2008)
2002  
16
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder.
[11806838] Respir Res 3(-): 3 (2002)
2005  
17
Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findings.
[16304008] AJR Am J Roentgenol 185(6): 1531-9 (2005)
1998  
18
The role of eosinophils in pulmonary fibrosis (Review).
[9852197] Int J Mol Med 1(1): 43-53 (1998)
2004  
19
Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment.
[15262886] CMAJ 171(2): 153-60 (2004)
2010  
20
What can biomarkers tell us about the pathogenesis of acute exacerbations of idiopathic pulmonary fibrosis?
[20472711] Am J Physiol Lung Cell Mol Physiol 299(1): L1-2 (2010)
2008  
21
Animal models of pulmonary fibrosis: how far from effective reality?
[18156439] Am J Physiol Lung Cell Mol Physiol 294(2): L151 (2008)
2010  
22
Workshop on idiopathic pulmonary fibrosis in older adults.
[20822991] Chest 138(3): 693-703 (2010)
2004  
23
The role of transforming growth factor beta in lung development and disease.
[14769761] Chest 125(2): 754-65 (2004)
2004  
24
Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis.
[15302729] Chest 126(2): 438-46 (2004)
2007  
25
Pulmonary hypertension in idiopathic pulmonary fibrosis.
[17873194] Chest 132(3): 998-1006 (2007)
2007  
26
Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis.
[17356077] Chest 131(3): 657-63 (2007)
2007  
27
The impact of pulmonary arterial hypertension on idiopathic pulmonary fibrosis.
[17356072] Chest 131(3): 641-3 (2007)
2005  
28
Diagnosis: to biopsy or not to biopsy: assessing the role of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis.
[16304242] Chest 128(5 Suppl 1): 520S-525S (2005)
2008  
29
Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?
[18574287] Chest 133(6): 1442-50 (2008)
2009  
30
New mechanisms of pulmonary fibrosis.
[19892675] Chest 136(5): 1364-70 (2009)
2006  
31
Fibroblastic foci: time to be counted?
[16840372] Chest 130(1): 3-5 (2006)
2008  
32
Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality.
[18235106] Radiology 246(3): 935-40 (2008)
2007  
33
Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.
[17684287] Proc Am Thorac Soc 4(5): 449-52 (2007)
2006  
34
Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.
[16738200] Proc Am Thorac Soc 3(4): 350-6 (2006)
2007  
35
Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis.
[17600295] Thorax 62(7): 638-49 (2007)
2007  
36
Challenges in pulmonary fibrosis. 3: Cystic lung disease.
[17726170] Thorax 62(9): 820-29 (2007)
2007  
37
Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases.
[17909189] Thorax 62(10): 904-10 (2007)
2006  
38
IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?
[17008481] Thorax 61(10): 835-6 (2006)
2011  
39
Novel therapeutic approaches for pulmonary fibrosis.
[21265830] Br J Pharmacol 163(1): 141-72 (2011)
2008  
40
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
[17936056] Int J Biochem Cell Biol 40(3): 362-82 (2008)
2005  
41
Lung inflammation and fibrosis: an alveolar macrophage-centered perspective from the 1970s to 1980s.
[15557133] Am J Respir Crit Care Med 171(2): 98-102 (2005)
2008  
42
Etanercept for idiopathic pulmonary fibrosis: lessons on clinical trial design.
[18945868] Am J Respir Crit Care Med 178(9): 889-91 (2008)
2007  
43
Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.
[17255562] Am J Respir Crit Care Med 175(9): 875-80 (2007)
2009  
44
Fibrocytes as potential biomarkers in idiopathic pulmonary fibrosis.
[19318541] Am J Respir Crit Care Med 179(7): 524-5 (2009)
2008  
45
Idiopathic pulmonary fibrosis: a disorder of lung regeneration?
[18796651] Am J Respir Crit Care Med 178(7): 663-5 (2008)
2008  
46
High-resolution computed tomography and the many faces of idiopathic pulmonary fibrosis.
[18250354] Am J Respir Crit Care Med 177(4): 367-8 (2008)
2009  
47
Advances in understanding of idiopathic pulmonary fibrosis.
[19493401] Chin Med J (Engl) 122(7): 844-57 (2009)
2010  
48
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology.
[20190329] Eur Respir J 35(3): 496-504 (2010)
2010  
49
Idiopathic pulmonary fibrosis and pirfenidone.
[20356985] Eur Respir J 35(4): 728-9 (2010)
2006  
50
Idiopathic pulmonary fibrosis: a decade of progress.
[17273615] J Bras Pneumol 32(3): 249-60 (2006)
2008  
51
Roles of T lymphocytes in pulmonary fibrosis.
[17962367] J Leukoc Biol 83(2): 237-44 (2008)
2009  
52
The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis.
[19581373] J Leukoc Biol 86(5): 1111-8 (2009)
2010  
53
Idiopathic pulmonary fibrosis is associated with endothelial to mesenchymal transition.
[20651063] Am J Respir Cell Mol Biol 43(2): 129-30 (2010)
2006  
54
Telomerase, myofibroblasts, and pulmonary fibrosis.
[16618786] Am J Respir Cell Mol Biol 34(5): 520-2 (2006)
2003  
55
Epithelial cell modulation of airway fibrosis in asthma.
[12540477] Am J Respir Cell Mol Biol 28(2): 125-8 (2003)
2010  
56
Potential role of endothelin-1 in pulmonary fibrosis: from the bench to the clinic.
[19717811] Am J Respir Cell Mol Biol 42(1): 16-20 (2010)
2010  
57
The quest for the initial lesion in idiopathic pulmonary fibrosis: gene expression differences in IPF fibroblasts.
[20026648] Am J Respir Cell Mol Biol 42(1): 1-2 (2010)
2005  
58
Back to the future: historical perspective on the pathogenesis of idiopathic pulmonary fibrosis.
[16024580] Am J Respir Cell Mol Biol 33(2): 113-20 (2005)
2012  
59
Right place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosis.
[22180659] Am J Physiol Lung Cell Mol Physiol 302(5): L441-4 (2012)
2011  
60
New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.
[21668038] Drugs 71(8): 981-1001 (2011)
2010  
61
Effect of treatment guidelines on the initial management of idiopathic pulmonary fibrosis.
[20642554] Br J Clin Pharmacol 70(1): 118-25 (2010)
2011  
62
Pirfenidone treatment of idiopathic pulmonary fibrosis.
[21339942] Ther Clin Risk Manag 7(-): 39-47 (2011)
2009  
63
The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis.
[19768162] Trans Am Clin Climatol Assoc 120(-): 49-59 (2009)
2010  
64
Clinical use of biomarkers of survival in pulmonary fibrosis.
[20584284] Respir Res 11(-): 89 (2010)
2011  
65
Fibrocytes and the tissue niche in lung repair.
[21658209] Respir Res 12(-): 76 (2011)
2010  
66
Investigational approaches to therapies for idiopathic pulmonary fibrosis.
[20443753] Expert Opin Investig Drugs 19(6): 737-45 (2010)
2009  
67
Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease.
[20143918] Lymphat Res Biol 7(4): 197-203 (2009)
2003  
68
Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.
[14595745] J Pathol 201(3): 343-54 (2003)
2011  
69
Gastroesophageal reflux and idiopathic pulmonary fibrosis: a review.
[21738875] Pulm Med 2011(-): 634613 (2011)
2010  
70
The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis.
[20055532] BioDrugs 24(1): 49-54 (2010)
2005  
71
A critical assessment of treatment options for idiopathic pulmonary fibrosis.
[16315778] Sarcoidosis Vasc Diffuse Lung Dis 22(3): 167-74 (2005)
2006  
72
Epithelial-mesenchymal interactions in pulmonary fibrosis.
[17195137] Semin Respir Crit Care Med 27(6): 600-12 (2006)
2006  
73
Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.
[16928146] Treat Respir Med 5(5): 325-42 (2006)
2011  
74
Telomere dysfunction in human bone marrow failure syndromes.
[21647296] Nucleus 2(1): 24-9 (2011)
2009  
75
Pulmonary fibrosis: pathogenesis, etiology and regulation.
[19129758] Mucosal Immunol 2(2): 103-21 (2009)
2011  
76
Hepatocyte growth factor in lung repair and pulmonary fibrosis.
[21131996] Acta Pharmacol Sin 32(1): 12-20 (2011)
PMC   
77
The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.
[24454287] Front Pharmacol 4():173 (2014)
PMC   
78
Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis.
[24478703] Front Pharmacol 5():2 (2014)
PMC   
79
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis.
[23186614] Respir Med 107(2):249-55 (2013)
PMC   
80
High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis.
[24479411] Respir Res 15():10 (2014)
PMC   
81
The treatment of idiopathic pulmonary fibrosis.
[24669297] F1000Prime Rep 6(): (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lung (Fibrosis).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lung (Fibrosis).php on line 92